ALX Oncology to Participate in Upcoming Investor Conferences in September
ALX Oncology (NASDAQ:ALXO), a clinical-stage biotech company focused on cancer therapies, has announced its participation in two upcoming investor conferences in September 2025. The company will attend the Cantor Global Healthcare Conference on September 3, featuring a fireside chat at 9:45 AM ET, and the H.C. Wainwright 27th Annual Global Investment Conference on September 9.
Both events will be held in New York and will include one-on-one meetings. Webcasts of the presentations will be available on ALX Oncology's website and archived for up to 90 days.
ALX Oncology (NASDAQ:ALXO), azienda biofarmaceutica in fase clinica focalizzata sulle terapie antitumorali, ha annunciato la partecipazione a due conferenze per investitori previste per settembre 2025. La società sarà presente al Cantor Global Healthcare Conference il 3 settembre, con un fireside chat alle 9:45 AM ET, e all'H.C. Wainwright 27th Annual Global Investment Conference il 9 settembre.
Entrambi gli eventi si terranno a New York e includeranno incontri one-to-one. Le webcast delle presentazioni saranno disponibili sul sito di ALX Oncology e archiviate per un massimo di 90 giorni.
ALX Oncology (NASDAQ:ALXO), una biotecnológica en fase clínica centrada en terapias contra el cáncer, ha anunciado su participación en dos conferencias para inversores en septiembre de 2025. La compañía asistirá al Cantor Global Healthcare Conference el 3 de septiembre, con un fireside chat a las 9:45 AM ET, y al H.C. Wainwright 27th Annual Global Investment Conference el 9 de septiembre.
Ambos eventos se celebrarán en Nueva York e incluirán reuniones individuales. Las retransmisiones en directo de las presentaciones estarán disponibles en la web de ALX Oncology y se archivarán hasta por 90 días.
ALX Oncology (NASDAQ:ALXO), 암 치료제 개발에 주력하는 임상 단계 바이오기업이 2025년 9월 개최되는 두 건의 투자자 컨퍼런스 참여를 발표했습니다. 회사는 9월 3일 Cantor Global Healthcare Conference에서 오전 9시45분(동부시간)에 파이어사이드 채팅을 진행하고, 9월 9일에는 H.C. Wainwright 27th Annual Global Investment Conference에 참석합니다.
두 행사는 모두 뉴욕에서 열리며 일대일 미팅도 예정되어 있습니다. 발표 웹캐스트는 ALX Oncology 웹사이트에서 시청할 수 있으며 최대 90일간 아카이브됩니다.
ALX Oncology (NASDAQ:ALXO), société biotechnologique en phase clinique spécialisée dans les traitements du cancer, a annoncé sa participation à deux conférences investisseurs en septembre 2025. La société assistera au Cantor Global Healthcare Conference le 3 septembre, avec un fireside chat à 9h45 (ET), et au H.C. Wainwright 27th Annual Global Investment Conference le 9 septembre.
Les deux événements se tiendront à New York et comprendront des réunions individuelles. Les webcasts des présentations seront disponibles sur le site d'ALX Oncology et archivés pendant 90 jours au maximum.
ALX Oncology (NASDAQ:ALXO), ein biopharmazeutisches Unternehmen in der klinischen Phase mit Schwerpunkt auf Krebstherapien, hat seine Teilnahme an zwei Investorenkonferenzen im September 2025 angekündigt. Das Unternehmen wird am Cantor Global Healthcare Conference am 3. September mit einem Fireside-Chat um 9:45 Uhr ET sowie am H.C. Wainwright 27th Annual Global Investment Conference am 9. September teilnehmen.
Beide Veranstaltungen finden in New York statt und umfassen Einzelgespräche. Webcasts der Präsentationen werden auf der Website von ALX Oncology verfügbar sein und bis zu 90 Tage archiviert.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced that ALX Oncology leadership will participate in both the Cantor Global Healthcare Conference 2025 and H.C. Wainwright 27th Annual Global Investment Conference in New York.
The details of the meetings are as follows:
Cantor Global Healthcare Conference
Format: Fireside Chat and One-on-one Meetings
Date: Wednesday, September 3, 2025
Location: New York, NY
Time of Fireside Chat Presentation: 9:45 AM ET
Webcast link: Available here
H.C. Wainwright 27th Annual Global Investment Conference
Format: One-on-one meetings
Date: Tuesday, September 9, 2025
Location: New York, NY
Webcast link: Pre-recorded fireside chat presentation available here
The webcasts of the Cantor and H.C. Wainwright fireside chats can be accessed by visiting the Investors section of ALX Oncology’s website at www.alxoncology.com under the Events section of the Events and Presentations tab. Replays of the webcasts will be archived for up to 90 days following the fireside chat dates.
About ALX Oncology
ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives. ALX Oncology’s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications. ALX Oncology’s second pipeline candidate, ALX2004, is a novel EGFR-targeted antibody-drug conjugate with a differentiated mechanism of action and entered the clinic in a Phase 1 trial in August 2025. More information is available at www.alxoncology.com and on LinkedIn @ALX Oncology.
Investor Relations Contact:
Elhan Webb, CFA, IR Consultant
ewebb@alxoncology.com
Media Contact:
Audra Friis, Sam Brown Healthcare Communications
audrafriis@sambrown.com
(917) 519-9577
FAQ
When is ALX Oncology (ALXO) presenting at the Cantor Global Healthcare Conference 2025?
Where can I watch ALX Oncology's (ALXO) investor conference presentations?
Which investor conferences is ALX Oncology (ALXO) attending in September 2025?
What type of company is ALX Oncology (ALXO)?
